Home > Publications database > Defective homologous recombination DNA repair as therapeutic target in advanced chordoma. > print |
001 | 143513 | ||
005 | 20240229112555.0 | ||
024 | 7 | _ | |a 10.1038/s41467-019-09633-9 |2 doi |
024 | 7 | _ | |a pmid:30967556 |2 pmid |
024 | 7 | _ | |a pmc:PMC6456501 |2 pmc |
024 | 7 | _ | |a altmetric:58778611 |2 altmetric |
037 | _ | _ | |a DKFZ-2019-01097 |
041 | _ | _ | |a eng |
082 | _ | _ | |a 500 |
100 | 1 | _ | |a Gröschel, Stefan |0 P:(DE-He78)5120a331b1c28045c8ca6a8b1c73c95f |b 0 |e First author |
245 | _ | _ | |a Defective homologous recombination DNA repair as therapeutic target in advanced chordoma. |
260 | _ | _ | |a [London] |c 2019 |b Nature Publishing Group UK |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1668599538_5814 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a Chordomas are rare bone tumors with few therapeutic options. Here we show, using whole-exome and genome sequencing within a precision oncology program, that advanced chordomas (n = 11) may be characterized by genomic patterns indicative of defective homologous recombination (HR) DNA repair and alterations affecting HR-related genes, including, for example, deletions and pathogenic germline variants of BRCA2, NBN, and CHEK2. A mutational signature associated with HR deficiency was significantly enriched in 72.7% of samples and co-occurred with genomic instability. The poly(ADP-ribose) polymerase (PARP) inhibitor olaparib, which is preferentially toxic to HR-incompetent cells, led to prolonged clinical benefit in a patient with refractory chordoma, and whole-genome analysis at progression revealed a PARP1 p.T910A mutation predicted to disrupt the autoinhibitory PARP1 helical domain. These findings uncover a therapeutic opportunity in chordoma that warrants further exploration, and provide insight into the mechanisms underlying PARP inhibitor resistance. |
536 | _ | _ | |a 311 - Signalling pathways, cell and tumor biology (POF3-311) |0 G:(DE-HGF)POF3-311 |c POF3-311 |f POF III |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
700 | 1 | _ | |a Hübschmann, Daniel |0 P:(DE-HGF)0 |b 1 |e First author |
700 | 1 | _ | |a Raimondi, Francesco |b 2 |
700 | 1 | _ | |a Horak, Peter |0 P:(DE-He78)5ea1944c122bc098a81df27a05572719 |b 3 |
700 | 1 | _ | |a Warsow, Gregor |0 P:(DE-He78)13b64bdd8d9a2fdb2ab13cc480819130 |b 4 |
700 | 1 | _ | |a Fröhlich, Martina |0 P:(DE-He78)a15aa7d740f286aad9d8139d515e866c |b 5 |
700 | 1 | _ | |a Klink, Barbara |0 0000-0002-8753-8238 |b 6 |
700 | 1 | _ | |a Gieldon, Laura |0 P:(DE-He78)faeda50a6b472b04206eb573f9894d21 |b 7 |
700 | 1 | _ | |a Hutter, Barbara |0 P:(DE-He78)135e8c8d1dd1b66b8127c3d1e3a9b6a0 |b 8 |
700 | 1 | _ | |a Kleinheinz, Kortine |0 P:(DE-He78)e053817bc90becc8a8dd8250e677e773 |b 9 |
700 | 1 | _ | |a Bonekamp, David |0 P:(DE-He78)ea098e4d78abeb63afaf8c25ec6d6d93 |b 10 |
700 | 1 | _ | |a Marschal, Oliver |b 11 |
700 | 1 | _ | |a Chudasama, Priya |0 P:(DE-He78)97208bef945f0ab6bf33ed9925685de4 |b 12 |
700 | 1 | _ | |a Mika, Jagoda |0 P:(DE-He78)07af613eea059030daaed3bde1fd1ce7 |b 13 |
700 | 1 | _ | |a Groth, Marie |b 14 |
700 | 1 | _ | |a Uhrig, Sebastian |0 P:(DE-He78)a8e85c1bd89741ab0c2a28032ba81359 |b 15 |
700 | 1 | _ | |a Krämer, Stephen |0 P:(DE-He78)27e428a621a82fda81b0d5a1ccab3907 |b 16 |
700 | 1 | _ | |a Heining, Christoph |0 P:(DE-He78)1464357f7ec5faf677a390a414e50c88 |b 17 |
700 | 1 | _ | |a Heilig, Christoph |0 P:(DE-He78)42b6114cd48e033299b2b6ef4bf56cc6 |b 18 |
700 | 1 | _ | |a Richter, Daniela |0 P:(DE-He78)29306fd3ae9f1a9839ed888ebc5c8074 |b 19 |
700 | 1 | _ | |a Reisinger, Eva |0 P:(DE-He78)63ceb91f3d4f8750e9e1b4967d6aab75 |b 20 |
700 | 1 | _ | |a Pfütze, Katrin |0 P:(DE-He78)83906db1355a576371363a4b9f107d3d |b 21 |
700 | 1 | _ | |a Eils, Roland |0 P:(DE-He78)78b6aa82148e60b4d91e3a37a6d3d9a0 |b 22 |
700 | 1 | _ | |a Wolf, Stephan |0 P:(DE-He78)1efb774993effe7a66a6ffc1b1cf9ccb |b 23 |
700 | 1 | _ | |a von Kalle, Christof |0 P:(DE-He78)5bacb661d5d7c0220d8f996d980ad8de |b 24 |
700 | 1 | _ | |a Brandts, Christian |0 P:(DE-HGF)0 |b 25 |
700 | 1 | _ | |a Scholl, Claudia |0 P:(DE-He78)2c1a21d1cf5fdc9e297512c9d1354250 |b 26 |
700 | 1 | _ | |a Weichert, Wilko |0 P:(DE-HGF)0 |b 27 |
700 | 1 | _ | |a Richter, Stephan |b 28 |
700 | 1 | _ | |a Bauer, Sebastian |0 P:(DE-HGF)0 |b 29 |
700 | 1 | _ | |a Penzel, Roland |0 P:(DE-HGF)0 |b 30 |
700 | 1 | _ | |a Schröck, Evelin |0 P:(DE-HGF)0 |b 31 |
700 | 1 | _ | |a Stenzinger, Albrecht |0 P:(DE-HGF)0 |b 32 |
700 | 1 | _ | |a Schlenk, Richard |0 P:(DE-He78)d8a0e60e5e095f3161ee0de3712409bc |b 33 |
700 | 1 | _ | |a Brors, Benedikt |0 P:(DE-He78)fc949170377b58098e46141d95c72661 |b 34 |
700 | 1 | _ | |a Russell, Robert B |0 0000-0002-1905-4717 |b 35 |
700 | 1 | _ | |a Glimm, Hanno |0 P:(DE-He78)157277fe62f07df1732f9d126a51d1b9 |b 36 |e Last author |
700 | 1 | _ | |a Schlesner, Matthias |0 P:(DE-He78)f2a782242acf94a3114d75c45dc75b37 |b 37 |e Last author |
700 | 1 | _ | |a Fröhling, Stefan |0 P:(DE-He78)f0144d171d26dbedb67c9db1df35629d |b 38 |e Last author |
773 | _ | _ | |a 10.1038/s41467-019-09633-9 |g Vol. 10, no. 1, p. 1635 |0 PERI:(DE-600)2553671-0 |n 1 |p 1635 |t Nature Communications |v 10 |y 2019 |x 2041-1723 |
909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:143513 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-He78)5120a331b1c28045c8ca6a8b1c73c95f |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-HGF)0 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 3 |6 P:(DE-He78)5ea1944c122bc098a81df27a05572719 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 4 |6 P:(DE-He78)13b64bdd8d9a2fdb2ab13cc480819130 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 5 |6 P:(DE-He78)a15aa7d740f286aad9d8139d515e866c |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 7 |6 P:(DE-He78)faeda50a6b472b04206eb573f9894d21 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 8 |6 P:(DE-He78)135e8c8d1dd1b66b8127c3d1e3a9b6a0 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 9 |6 P:(DE-He78)e053817bc90becc8a8dd8250e677e773 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 10 |6 P:(DE-He78)ea098e4d78abeb63afaf8c25ec6d6d93 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 12 |6 P:(DE-He78)97208bef945f0ab6bf33ed9925685de4 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 13 |6 P:(DE-He78)07af613eea059030daaed3bde1fd1ce7 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 15 |6 P:(DE-He78)a8e85c1bd89741ab0c2a28032ba81359 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 16 |6 P:(DE-He78)27e428a621a82fda81b0d5a1ccab3907 |
910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 17 |6 P:(DE-He78)1464357f7ec5faf677a390a414e50c88 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 18 |6 P:(DE-He78)42b6114cd48e033299b2b6ef4bf56cc6 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 19 |6 P:(DE-He78)29306fd3ae9f1a9839ed888ebc5c8074 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 20 |6 P:(DE-He78)63ceb91f3d4f8750e9e1b4967d6aab75 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 21 |6 P:(DE-He78)83906db1355a576371363a4b9f107d3d |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 22 |6 P:(DE-He78)78b6aa82148e60b4d91e3a37a6d3d9a0 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 23 |6 P:(DE-He78)1efb774993effe7a66a6ffc1b1cf9ccb |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 24 |6 P:(DE-He78)5bacb661d5d7c0220d8f996d980ad8de |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 25 |6 P:(DE-HGF)0 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 26 |6 P:(DE-He78)2c1a21d1cf5fdc9e297512c9d1354250 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 27 |6 P:(DE-HGF)0 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 29 |6 P:(DE-HGF)0 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 30 |6 P:(DE-HGF)0 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 31 |6 P:(DE-HGF)0 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 32 |6 P:(DE-HGF)0 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 33 |6 P:(DE-He78)d8a0e60e5e095f3161ee0de3712409bc |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 34 |6 P:(DE-He78)fc949170377b58098e46141d95c72661 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 36 |6 P:(DE-He78)157277fe62f07df1732f9d126a51d1b9 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 37 |6 P:(DE-He78)f2a782242acf94a3114d75c45dc75b37 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 38 |6 P:(DE-He78)f0144d171d26dbedb67c9db1df35629d |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-311 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Signalling pathways, cell and tumor biology |x 0 |
914 | 1 | _ | |y 2019 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b NAT COMMUN : 2017 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Blind peer review |
915 | _ | _ | |a Creative Commons Attribution CC BY (No Version) |0 LIC:(DE-HGF)CCBYNV |2 V:(DE-HGF) |b DOAJ |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1060 |2 StatID |b Current Contents - Agriculture, Biology and Environmental Sciences |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1150 |2 StatID |b Current Contents - Physical, Chemical and Earth Sciences |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1040 |2 StatID |b Zoological Record |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
915 | _ | _ | |a IF >= 10 |0 StatID:(DE-HGF)9910 |2 StatID |b NAT COMMUN : 2017 |
920 | 1 | _ | |0 I:(DE-He78)A380-20160331 |k A380 |l NWG Molekulare Leukämogenese |x 0 |
920 | 1 | _ | |0 I:(DE-He78)L101-20160331 |k L101 |l DKTK Heidelberg |x 1 |
920 | 1 | _ | |0 I:(DE-He78)B080-20160331 |k B080 |l Theoretische Bioinformatik |x 2 |
920 | 1 | _ | |0 I:(DE-He78)A010-20160331 |k A010 |l A010 Stammzellen und Krebs |x 3 |
920 | 1 | _ | |0 I:(DE-He78)B340-20160331 |k B340 |l Translationale Medizinische Onkologie |x 4 |
920 | 1 | _ | |0 I:(DE-He78)B240-20160331 |k B240 |l Bioinformatik und Omics Data Analytics |x 5 |
920 | 1 | _ | |0 I:(DE-He78)B330-20160331 |k B330 |l Angewandte Bioinformatik |x 6 |
920 | 1 | _ | |0 I:(DE-He78)E010-20160331 |k E010 |l E010 Radiologie |x 7 |
920 | 1 | _ | |0 I:(DE-He78)A360-20160331 |k A360 |l KKE Mol. Hämatologie/Onkologie |x 8 |
920 | 1 | _ | |0 I:(DE-He78)W190-20160331 |k W190 |l Hochdurchsatz-Sequenzierung |x 9 |
920 | 1 | _ | |0 I:(DE-He78)B290-20160331 |k B290 |l Angewandte Funktionelle Genomik |x 10 |
920 | 1 | _ | |0 I:(DE-He78)L301-20160331 |k L301 |l DKTK Dresden |x 11 |
920 | 1 | _ | |0 I:(DE-He78)L501-20160331 |k L501 |l DKTK Frankfurt |x 12 |
920 | 1 | _ | |0 I:(DE-He78)L701-20160331 |k L701 |l DKTK München |x 13 |
920 | 1 | _ | |0 I:(DE-He78)L401-20160331 |k L401 |l DKTK Essen |x 14 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)A380-20160331 |
980 | _ | _ | |a I:(DE-He78)L101-20160331 |
980 | _ | _ | |a I:(DE-He78)B080-20160331 |
980 | _ | _ | |a I:(DE-He78)A010-20160331 |
980 | _ | _ | |a I:(DE-He78)B340-20160331 |
980 | _ | _ | |a I:(DE-He78)B240-20160331 |
980 | _ | _ | |a I:(DE-He78)B330-20160331 |
980 | _ | _ | |a I:(DE-He78)E010-20160331 |
980 | _ | _ | |a I:(DE-He78)A360-20160331 |
980 | _ | _ | |a I:(DE-He78)W190-20160331 |
980 | _ | _ | |a I:(DE-He78)B290-20160331 |
980 | _ | _ | |a I:(DE-He78)L301-20160331 |
980 | _ | _ | |a I:(DE-He78)L501-20160331 |
980 | _ | _ | |a I:(DE-He78)L701-20160331 |
980 | _ | _ | |a I:(DE-He78)L401-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|